Veritas Aortic Solutions Raises $12 Million in Seed Funding
Veritas Aortic Solutions, headquartered in Costa Mesa, California, has successfully closed a $12 million seed funding round. The investment was made by Cedars-Sinai Intellectual Property Company and inQB8, marking a significant step for the company as it aims to advance its offerings in the medical technology sector.
Company Overview
Veritas Aortic Solutions is focused on developing innovative solutions for aortic disease management. With a mission to enhance patient outcomes, the company is at the forefront of creating new technologies that address critical needs in cardiovascular healthcare.
Leadership Team
The company was co-founded by Arshad Quadri, who serves as the Executive Chairman and Chief Medical Officer, and Brent Ratz, who holds the position of CEO. Together, they bring a wealth of experience to the company. Ratz commented on the funding round, saying, "This investment will enable us to accelerate the development of our technology and bring it to patients more quickly."
Investors
The seed round was supported by Cedars-Sinai Intellectual Property Company and inQB8. These investors are known for backing companies that have the potential to transform healthcare with innovative solutions.
Use of Funds
The newly acquired funds are expected to be directed towards research and development, expanding the company's product pipeline, and potentially increasing its workforce to support these initiatives. The focus will be on enhancing their current technological capabilities and preparing for market entry.
Conclusion
This seed funding marks a pivotal moment for Veritas Aortic Solutions, providing the necessary resources to advance their mission of improving aortic disease treatments. With strong backing from reputable investors, the company is well-positioned to make significant strides in the medical technology field.